Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.57 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3037609 | 1.00 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL12638422 | 1.00 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL3043744 | 1.00 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL417495 | 1.00 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL923466 | 1.00 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Water SCHEMBL23525630 | 0.97 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Hydrochloric Acid SCHEMBL29716086 | 0.97 | BBOX1 (0.56) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Water SCHEMBL14914647 | 0.97 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Bromide SCHEMBL14914316 | 0.97 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Water SCHEMBL14861565 | 0.97 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2174911-A1 | Method for preparing a zeolite with MTW-type structure | IFP (FR) | 2010-04-14 | — | — | EP | claimed |
| US-8999298-B2 | Dental oral composition | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| US-8147807-B2 | Oral composition for dental purposes | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20100330005-A1 | DENTAL ORAL COMPOSITION | KURARAY MEDICAL INC. (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100240714-A1 | ORAL COMPOSITION FOR DENTAL PURPOSES | NAT. UNI. CORP. OKAYAMA UNIVERSITY (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2174911-A1 | Method for preparing a zeolite with MTW-type structure | IFP (FR) | 2010-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330005-A1 | DENTAL ORAL COMPOSITION | TAS2R42, TAS2R43, PPM1G | LMNA 4782/4885APOBEC3A 3603/4885APOBEC3G 3671/4885 |
| US-20100240714-A1 | ORAL COMPOSITION FOR DENTAL PURPOSES | DDOST, PPM1G, PHOSPHO1 | LMNA 4854/4885APOBEC3A 4221/4885APOBEC3G 3781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.